Operating Data

Vaxart Inc

Vaxart Inc (VXRT)

$6.6978
-0.4922 (-6.85%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
Revenue 33.6068.7024.609.305.844.169.8610.6711.5512.4913.5214.63
Revenue (%)
EBITDA -4.50-8.70-17.80-25.20-8.84-13.87-14.24-15.23-16.47-17.83-19.29-20.87
EBITDA (%)
EBIT -7.50-11.10-18.90-25.30-9.22-17.08-17.84-17.33-18.75-20.29-21.95-23.75
EBIT (%)
Depreciation 3.002.401.100.100.383.203.602.102.282.462.662.88
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)